Zymeworks is pleased to announce the acceptance of an abstract for poster presentation at the Society for Immunotherapy of Cancer (SITC) Conference taking place in Boston, MA from November 8 to November 12, 2022.
Title: Optimization of purine-based TLR7 agonists as payloads for immune-stimulating antibody conjugates (ISACs)
Poster Number: 1185
Date and Time: November 10, 2022 at 9:00 am – 9:00 pm ET
Location: Boston Convention & Exhibition Center, Hall C
The presentation will be available to conference registrants on the conference website as well as to the general public at www.zymeworks.com/publications at the time of presentation at the conference.